Skip to main content

Frequency Exchange: Top 10 Undervalued Medical Devices & Instruments Industry Sector Stocks on TSX Venture Exchange (FREQ)

The Globe and Mail - Mon Sep 5, 2022
Industry Group

Frequency Exchange is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).

All data provided as-at market close September 01, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. Frequency Exchange Frequency Exchange Corp focused on the development and commercialization of a frequency emitter that delivers a special package of frequencies designed for the health and wellness market, specifically to target Lyme disease within North America. Frequency Exchange is listed under FREQ on the TSX Venture Exchange.

Symbol

Name

Close Price

Shares Outstanding

P/E

P/B

Cash per Share

Net Cash per Share

MDX-XMedx Health000000
FREQ-XFrequency Exchange000000
QIPT-XQuipt Home Medical000000
TEST-XFluroTech000000
SGMD-XSalona Global Medical000000
ASG-XAurora Spine000000
PINK-XPerimeter Medical Imaging000000
NGMD-XNuGen Medical Devices000000
THRM-XTherma Bright000000
LXG-XLexagene Holdings000000

More about Frequency Exchange

Medical Devices & Instruments: Companies that develop, manufacture, and market medical and surgical equipment and machinery, including orthopedic products, respiratory care equipment, x-ray equipment, laser systems, implants, pacemakers, and other major medical machines and apparatus.. Stocks in this category are held primarily for capital appreciation.

Artificial intelligence at Report on Business

Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.